This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07019/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07019/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07019/identifier/pubchem-substance/
n10http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB07019/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07019
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB07019 n10:DB07019
dcterms:title
N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE
adms:identifier
n4:DB07019 n9:99443490 n12:35A n13:24768527
n5:IUPAC-Name
n6:271B41A3-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B41A9-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B41A8-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B41A5-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B41A6-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B41A7-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B41A1-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B41A2-363D-11E5-9242-09173F13E4C5 n6:271B419F-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B41A0-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B41AF-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B41B0-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B41AA-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B41AB-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B41AD-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B41AC-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B41AE-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B41B4-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B41B6-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B41B7-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B41B3-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B41B2-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B41B5-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B41A4-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B41B1-363D-11E5-9242-09173F13E4C5